BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heo Y, Syed YY. Subcutaneous Trastuzumab: A Review in HER2-Positive Breast Cancer. Targ Oncol 2019;14:749-58. [DOI: 10.1007/s11523-019-00684-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lorusso M, Scolozzi V, Taralli S, Caldarella C, Altini C, Rubini G, Calcagni ML. Radiolabelled Trastuzumab PET/CT imaging: a promising non-invasive tool for the in vivo assessment of HER2 status in breast cancer patients. Clin Transl Imaging 2020;8:95-105. [DOI: 10.1007/s40336-020-00362-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang J, Zhang Y, Pi J, Xing D, Wang C. Localized delivery of immunotherapeutics: A rising trend in the field. J Control Release 2021;340:149-67. [PMID: 34699871 DOI: 10.1016/j.jconrel.2021.10.013] [Reference Citation Analysis]
3 Allmendinger A. Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products. Pharm Res 2021;38:739-57. [PMID: 33903976 DOI: 10.1007/s11095-021-03037-5] [Reference Citation Analysis]
4 Zhu M, Tang X, Gong Z, Tang W, Zhang Y. TAD1822-7 induces ROS-mediated apoptosis of HER2 positive breast cancer by decreasing E-cadherin in an EphB4 dependent manner. Life Sci 2021;285:119954. [PMID: 34520770 DOI: 10.1016/j.lfs.2021.119954] [Reference Citation Analysis]
5 Davey MG, Kerin E, O'Flaherty C, Maher E, Richard V, McAnena P, McLaughlin RP, Sweeney KJ, Barry MK, Malone CM, Wyns W, Soliman O, Miller N, Keane MM, Lowery AJ, Kerin MJ. Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort study. Breast 2021;59:67-75. [PMID: 34171619 DOI: 10.1016/j.breast.2021.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]